Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Non-Current Deferred Tax Liability: 2019-2025

  • CureVac N.V's Non-Current Deferred Tax Liability was N/A to $256,955 in Q2 2025 from the same period last year, while for Jun 2025 it was $256,955, marking a year-over-year change of. This contributed to the annual value of $242,571 for FY2024, which is 96.58% down from last year.
  • According to the latest figures from Q2 2025, CureVac N.V's Non-Current Deferred Tax Liability is $256,955, which was up 7.61% from $238,778 recorded in Q1 2025.
  • CureVac N.V's 5-year Non-Current Deferred Tax Liability high stood at $7.1 million for Q4 2023, and its period low was $57,134 during Q4 2022.
  • Over the past 3 years, CureVac N.V's median Non-Current Deferred Tax Liability value was $249,763 (recorded in 2024), while the average stood at $2.0 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first soared by 12,297.05% in 2023, then crashed by 96.58% in 2024.
  • Quarterly analysis of 5 years shows CureVac N.V's Non-Current Deferred Tax Liability stood at $212,779 in 2021, then tumbled by 73.15% to $57,134 in 2022, then skyrocketed by 12,297.05% to $7.1 million in 2023, then crashed by 96.58% to $242,571 in 2024, then reached $256,955 in 2025.
  • Its last three reported values are $256,955 in Q2 2025, $238,778 for Q1 2025, and $242,571 during Q4 2024.